Lepore Patrick G
SEC-identified person · CIK 1055404 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Vyne Therapeutics Inc. VYNE | Director | filed 2020 - 2025 |
| Lannett CO INC LCI | Director | filed 2017 - 2022 |
| Matinas Biopharma Holdings, Inc. MTNB] | Director | filed 2018 - 2020 |
| Safari Holding Corp PMC | Director | filed 2013 - 2017 |
| Theravance INC thrx | Director | filed 2016 - 2017 |
| PAR Pharmaceutical Companies, INC. prx | Director · Executive Chairman | filed 2006 - 2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.